|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.88 USD | -0.29% |
|
+1.70% | -4.93% |
| 05-13 | Olink Holding's Q1 Net Loss Widens, Revenue Rises | MT |
| 05-13 | Olink Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May 10 (Reuters) - Britain's competition regulator said on Friday it has initiated a probe into U.S. medical equipment maker Thermo Fisher Scientific's $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
The Competition and Markets Authority (CMA) has set a deadline of July 8 for its phase 1 decision.
(Reporting by Eva Mathews in Bengaluru; Editing by Shinjini Ganguli)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 594.6 USD | -0.12% | +0.57% | 227B | ||
| 23.88 USD | -0.29% | +1.70% | 2.98B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -4.93% | 2.98B | |
| +10.35% | 8.27B | |
| +6.45% | 2.15B | |
| -28.04% | 1.1B | |
| +13.41% | 1.05B | |
| -3.29% | 865M | |
| -23.22% | 759M | |
| -53.81% | 708M | |
| -23.31% | 688M | |
| -30.98% | 623M |
OLINK HOLDING AB 
